FDA Clears Beckman Coulter’s phi Blood Test for Prostate Cancer

FDA approved Beckman Coulter’s Prostate Health Index (phi) blood test for detecting prostate cancer in patients with PSA values in the 4–10 ng/mL range.
Genetic Engineering & Biotechnology News